At Volpara, we’re on a mission to prevent advanced-stage cancer. By combining our groundbreaking Breast Health Platform with empowered patients, we are unleashing a revolution in cancer detection.
Check back for exciting updates to our website.
Personalized breast care for more women across all care settings
With the most scientifically validated technology platform in the breast health industry, Volpara is the preferred partner of leading clinical sites around the world.
VolparaEnterprise software provides ConstantQuality metrics and breast-specific key performance indicators to help your team perform at its very best, delivering the highest-quality breast imaging services.
Learn more about VolparaEnterprise
VolparaEnterprise Clinical Applications provide quick, automated assessment of every exam, producing a Volpara Scorecard that includes VolparaDensity, VolparaDose, and VolparaPressure.
Learn more about VolparaEnterprise DDP
VolparaDensity provides fast, objective assessment of a woman’s breast density from most digital mammography and tomosynthesis vendors.
Learn more about VolparaDensityVolpara Health is the wholly owned sales and marketing arm of Volpara Health Technologies Limited—an ISO13485- and ISO27001-certified, ISO14971- and FDA GMP–compliant research, development, and manufacturing company that develops digital health solutions to enable personalized, high-quality breast cancer screening based on objective measurements of breast density, compression, and radiation dose.
Volpara is the tool of choice for many researchers around the world. The Volpara suite of products provides ongoing information for improving clinical screening to population characteristics and breast cancer risk.
© 2021 Volpara Solutions Limited. All Rights Reserved.